当前位置:首页 - 行情中心 - 三力制药(603439) - 财务分析 - 现金流量表

三力制药

(603439)

  

流通市值:47.73亿  总市值:48.34亿
流通股本:4.04亿   总股本:4.09亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,326,555,727881,693,172.86440,689,494.522,030,745,473
  收到的税费返还1,694,742.2323,521.2323,383.853,640,668.41
  收到其他与经营活动有关的现金39,128,906.6320,400,752.1714,441,558.9137,915,232.23
  经营活动现金流入小计1,367,379,375.86902,117,446.26455,154,437.282,072,301,373.64
  购买商品、接受劳务支付的现金399,230,830.01269,478,920.98122,141,717.17572,082,427.1
  支付给职工以及为职工支付的现金250,116,414.12176,636,190.7586,155,535.73306,726,477.71
  支付的各项税费139,405,239.75111,917,580.2169,285,647.18214,442,102.18
  支付其他与经营活动有关的现金528,563,256.81327,137,433.28192,653,589.12871,977,782.23
  经营活动现金流出小计1,317,315,740.69885,170,125.22470,236,489.21,965,228,789.22
  经营活动产生的现金流量净额50,063,635.1716,947,321.04-15,082,051.92107,072,584.42
二、投资活动产生的现金流量:
  取得投资收益收到的现金494,460.46421,672.37142,189.031,611,642.49
  处置固定资产、无形资产和其他长期资产收回的现金净额458,987.5614,000574,000548,622.3
  收到的其他与投资活动有关的现金61,300,00054,400,00012,000,000190,000,000
  投资活动现金流入小计62,253,447.9655,435,672.3712,716,189.03192,160,264.79
  购建固定资产、无形资产和其他长期资产支付的现金23,814,915.9616,416,977.995,150,845.8545,198,116
  投资支付的现金206,830,000190,830,000172,830,00088,660,700
  支付其他与投资活动有关的现金98,099,654.0450,990,00044,390,000161,300,000
  投资活动现金流出小计328,744,570258,236,977.99222,370,845.85295,158,816
  投资活动产生的现金流量净额-266,491,122.04-202,801,305.62-209,654,656.82-102,998,551.21
三、筹资活动产生的现金流量:
  吸收投资收到的现金---63,425,000
  其中:子公司吸收少数股东投资收到的现金---24,200,000
  取得借款收到的现金449,638,000355,857,527.76119,156,787.76351,218,701.24
  筹资活动现金流入小计449,638,000355,857,527.76119,156,787.76414,643,701.24
  偿还债务支付的现金276,481,778.97202,425,000-299,850,000
  分配股利、利润或偿付利息支付的现金155,606,886.5149,329,036.55,325,574.14104,044,246.39
  其中:子公司支付给少数股东的股利、利润645,894654,894--
  支付其他与筹资活动有关的现金10,276,172.779,547,34452,009.59111,350,721.61
  筹资活动现金流出小计442,364,838.24361,301,380.55,377,583.73515,244,968
  筹资活动产生的现金流量净额7,273,161.76-5,443,852.74113,779,204.03-100,601,266.76
五、现金及现金等价物净增加额-209,154,325.11-191,297,837.32-110,957,504.71-96,527,233.55
  加:期初现金及现金等价物余额474,845,014.34474,843,014.34474,843,014.34571,370,247.89
  期末现金及现金等价物余额265,690,689.23283,545,177.02363,885,509.63474,843,014.34
补充资料:
  净利润-85,391,334.02-279,837,532.55
  资产减值准备-1,710,772.88-2,991,071.78
  固定资产和投资性房地产折旧-27,648,662.56-55,720,644.31
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-27,648,662.56-55,720,644.31
  无形资产摊销-9,536,629.65-19,100,408.98
  长期待摊费用摊销-156,641.64-293,577.96
  处置固定资产、无形资产和其他长期资产的损失--92,043.74-172,440.9
  固定资产报废损失-27,956.34-572,621.88
  公允价值变动损失--110,145.21--145,081.52
  财务费用-11,023,547.47-22,375,112.92
  投资损失--285,716.66--1,812,621.93
  递延所得税-2,047,166.12--7,461,434.15
  其中:递延所得税资产减少-285,926.32--4,082,709.61
    递延所得税负债增加-1,761,239.8--3,378,724.54
  存货的减少--44,963,470.68--147,988,187.38
  经营性应收项目的减少-155,370,548.7--295,557,206.15
  经营性应付项目的增加--234,839,818.47-167,692,205.83
  其他-7,298,301.73-147,652.59
  不涉及现金收支的投资和筹资活动金额其他项目---10,283,451.05
  现金的期末余额-283,545,177.02-474,843,014.34
  减:现金的期初余额-474,843,014.34-571,370,247.89
  现金及现金等价物的净增加额--191,297,837.32--96,527,233.55
公告日期2025-10-282025-08-282025-04-232025-04-23
审计意见(境内)标准无保留意见
TOP↑